12 March 2026
12 March 2026
The VISERA ELITE III supports various specialities, including general surgery, arthroscopy, and ENT.
The trial plans to enrol around 190 women aged 18 to 45 years across seven European countries.
Neupharma will fund and conduct a pivotal clinical trial in Japan to support regulatory approval.
FDA worked with GSK to update Wellcovorin labelling for safe, effective use in adult and paediatric CFD-FOLR1 patients.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
